daily oral glp-1 receptor agonist orforglipron for adults with obesity New pill reduces weight in trial Learn about Orforglipron a weight

Animal studies demonstrate retatrutides ability to delay gastric emptying, reduce food intake, and promote weight loss, with superior efficacy compared to other incretin-based therapies

It is taken daily and can sometimes be used off-label for weight management

Ordog T

This study should be interpreted in the context of several limitations, including (1) the impact of spelling errors on discussion mislabeling, (2) the inability to adjudicate reported side effects, (3) the demographic characteristics of Reddit authors which may limit generalizability, and (4) use of pre-existing general task benchmarks to drive LLM choice that may not optimally generalize to the topic labeling task

doi: 10.1371/journal.pone.0158205

Drug companies are scrambling for the biggest piece of that profitable pie